> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Draft Babesiosis Risk Reduction Guidance
- URL: https://www.fdaweb.com/draft-babesiosis-risk-reduction-guidance/
- Published: 2018-07-30T12:00:00.000Z
- Updated: 2026-09-15T00:22:34.000Z
- Author: David McFarland
- Tags: Biologics, #legacy-id-D5141999

FDA has issued a draft guidance, *Recommendations for Reducing the Risk of Transfusion-Transmitted Babesiosis*, with the agency’s assessment of babesiosis as a relevant transfusion-transmitted infection. The [document](https://www.fda.gov/downloads/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/Guidances/Blood/UCM614734.pdf?ref=fdaweb.com), directed to blood establishments that collect blood and blood components, contains recommendations for donor screening, donation testing, donor deferral, and product management to reduce the risk of transfusion-transmitted babesiosis. The guidance’s recommendations apply to collection of blood and blood components except source plasma.